T

Jia-Ling Zou1, Kai-Xiang Chen2, Xiao-Juan Wang2

  • 1Lab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China.

PubMed
概括

工程化单链T细胞受体 (scTCRs) 显示出更好的稳定性和可溶性. 这一进步有助于开发具有增强亲和力和保留特异性的T细胞受体治疗药物.